HEADER TRANSFERASE 12-SEP-03 1UNQ TITLE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF TITLE 2 PROTEIN KINASE B/AKT BOUND TO INS(1,3,4,5)-TETRAKISPHOPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PLECKSTRIN HOMOLOGY DOMAIN RESIDUES 1-123; COMPND 5 SYNONYM: PROTEIN KINASE B, RAC-PK-ALPHA, PKB, C-AKT; COMPND 6 EC: 2.7.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PGEX4T-1 KEYWDS TRANSFERASE, PLECKSTRIN HOMOLOGY DOMAIN, PKB, AKT, PHOSPHOINOSITIDE, KEYWDS 2 SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, PHOSPHORYLATION, KEYWDS 3 NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.C.MILBURN,M.DEAK,S.M.KELLY,N.C.PRICE,D.R.ALESSI,D.M.F.VAN AALTEN REVDAT 5 23-OCT-24 1UNQ 1 REMARK REVDAT 4 13-DEC-23 1UNQ 1 LINK REVDAT 3 28-FEB-18 1UNQ 1 SOURCE AUTHOR JRNL REVDAT 2 24-FEB-09 1UNQ 1 VERSN REVDAT 1 16-SEP-04 1UNQ 0 JRNL AUTH C.C.MILBURN,M.DEAK,S.M.KELLY,N.C.PRICE,D.R.ALESSI, JRNL AUTH 2 D.M.VAN AALTEN JRNL TITL BINDING OF PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE TO THE JRNL TITL 2 PLECKSTRIN HOMOLOGY DOMAIN OF PROTEIN KINASE B INDUCES A JRNL TITL 3 CONFORMATIONAL CHANGE. JRNL REF BIOCHEM. J. V. 375 531 2003 JRNL REFN ESSN 1470-8728 JRNL PMID 12964941 JRNL DOI 10.1042/BJ20031229 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.C.MILBURN,M.DEAK,D.R.ALESSI,D.M.F.VAN AALTEN REMARK 1 TITL HIGH RESOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN REMARK 1 TITL 2 OF PROTEIN KINASE B/AKT BOUND TO PHOSPHATIDYLINOSITOL REMARK 1 TITL 3 (3,4,5)-TRISPHOSPHATE REMARK 1 REF CURR.BIOL. V. 12 1256 2002 REMARK 1 REFN ISSN 0960-9822 REMARK 1 PMID 12176338 REMARK 1 DOI 10.1016/S0960-9822(02)00972-7 REMARK 2 REMARK 2 RESOLUTION. 0.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.151 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.154 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2429 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 60005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.142 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 46229 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 985 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 155 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1167.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 961.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 10 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 10871 REMARK 3 NUMBER OF RESTRAINTS : 13466 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.066 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.078 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.068 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.050 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.077 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UNQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1290013513. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920177 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60005 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.980 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.55700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1H10 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 30.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25 M AMMONIUM ACETATE, 30 % PEG REMARK 280 4000, 0.1 M SODIUM ACETATE (4.6), PH 4.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.45200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 17.19400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.45200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 17.19400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2055 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 118 REMARK 465 ASP A 119 REMARK 465 PHE A 120 REMARK 465 ARG A 121 REMARK 465 SER A 122 REMARK 465 GLY A 123 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 117 CA C O CB CG CD OE1 REMARK 470 GLU A 117 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 15 NE - CZ - NH1 ANGL. DEV. = 5.3 DEGREES REMARK 500 ARG A 15 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 67 NE - CZ - NH2 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 69 NE - CZ - NH1 ANGL. DEV. = -3.7 DEGREES REMARK 500 ARG A 69 NE - CZ - NH2 ANGL. DEV. = 4.8 DEGREES REMARK 500 ARG A 76 CD - NE - CZ ANGL. DEV. = 8.7 DEGREES REMARK 500 ARG A 76 NE - CZ - NH1 ANGL. DEV. = 7.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 80 -93.40 62.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 4IP A1117 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H10 RELATED DB: PDB REMARK 900 HIGH RESOLUTION STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF REMARK 900 PROTEIN KINASE B/AKT BOUND TO INS(1,3,4,5)-TETRAKISPHOPHATE REMARK 900 RELATED ID: 1UNP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN OF PKB ALPHA REMARK 900 RELATED ID: 1UNR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PH DOMAIN OF PKB ALPHA IN COMPLEX WITH A REMARK 900 SULFATE MOLECULE DBREF 1UNQ A -1 0 PDB 1UNQ 1UNQ -1 0 DBREF 1UNQ A 1 123 UNP P31749 KRAC_HUMAN 1 123 SEQRES 1 A 125 ACE SER MET SER ASP VAL ALA ILE VAL LYS GLU GLY TRP SEQRES 2 A 125 LEU HIS LYS ARG GLY GLU TYR ILE LYS THR TRP ARG PRO SEQRES 3 A 125 ARG TYR PHE LEU LEU LYS ASN ASP GLY THR PHE ILE GLY SEQRES 4 A 125 TYR LYS GLU ARG PRO GLN ASP VAL ASP GLN ARG GLU ALA SEQRES 5 A 125 PRO LEU ASN ASN PHE SER VAL ALA GLN CYS GLN LEU MET SEQRES 6 A 125 LYS THR GLU ARG PRO ARG PRO ASN THR PHE ILE ILE ARG SEQRES 7 A 125 CYS LEU GLN TRP THR THR VAL ILE GLU ARG THR PHE HIS SEQRES 8 A 125 VAL GLU THR PRO GLU GLU ARG GLU GLU TRP THR THR ALA SEQRES 9 A 125 ILE GLN THR VAL ALA ASP GLY LEU LYS LYS GLN GLU GLU SEQRES 10 A 125 GLU GLU MET ASP PHE ARG SER GLY HET ACE A -1 3 HET 4IP A1117 28 HETNAM ACE ACETYL GROUP HETNAM 4IP INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE FORMUL 1 ACE C2 H4 O FORMUL 2 4IP C6 H16 O18 P4 FORMUL 3 HOH *155(H2 O) HELIX 1 1 MET A 1 VAL A 4 5 4 HELIX 2 2 ASP A 44 GLU A 49 1 6 HELIX 3 3 THR A 92 GLU A 116 1 25 SHEET 1 AA 7 ASN A 53 SER A 56 0 SHEET 2 AA 7 THR A 34 TYR A 38 -1 O PHE A 35 N PHE A 55 SHEET 3 AA 7 TRP A 22 LYS A 30 -1 O TYR A 26 N TYR A 38 SHEET 4 AA 7 ILE A 6 ARG A 15 -1 N VAL A 7 O LEU A 29 SHEET 5 AA 7 THR A 82 HIS A 89 -1 O THR A 87 N ARG A 15 SHEET 6 AA 7 THR A 72 GLN A 79 -1 O PHE A 73 N PHE A 88 SHEET 7 AA 7 GLN A 61 THR A 65 -1 O GLN A 61 N ARG A 76 LINK C ACE A -1 N SER A 0 1555 1555 1.33 CISPEP 1 ARG A 67 PRO A 68 0 7.76 SITE 1 AC1 28 ACE A -1 SER A 0 MET A 1 SER A 2 SITE 2 AC1 28 HIS A 13 LYS A 14 GLY A 16 GLU A 17 SITE 3 AC1 28 TYR A 18 ILE A 19 ARG A 23 ARG A 25 SITE 4 AC1 28 LEU A 52 ASN A 53 PHE A 55 ARG A 86 SITE 5 AC1 28 HOH A2007 HOH A2105 HOH A2146 HOH A2147 SITE 6 AC1 28 HOH A2148 HOH A2149 HOH A2150 HOH A2151 SITE 7 AC1 28 HOH A2152 HOH A2153 HOH A2154 HOH A2155 CRYST1 82.904 34.388 44.292 90.00 115.29 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012062 0.000000 0.005699 0.00000 SCALE2 0.000000 0.029080 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024971 0.00000 HETATM 1 C ACE A -1 25.842 13.738 -11.519 1.00 14.57 C ANISOU 1 C ACE A -1 1596 2356 1583 -446 162 141 C HETATM 2 O ACE A -1 25.616 13.709 -10.308 1.00 19.54 O ANISOU 2 O ACE A -1 2186 3548 1689 -1087 329 171 O HETATM 3 CH3 ACE A -1 27.218 13.295 -12.006 1.00 17.56 C ANISOU 3 CH3 ACE A -1 2058 2378 2236 311 189 237 C